Exicure Signs Equity-Financing Deals With HiTron Systems

Dow Jones

2024-11-15

By Connor Hart

Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company.

The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday.

Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest.

Shares edged 1.3% lower, to $3.14, in after-hours trading.

The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

November 14, 2024 18:13 ET (23:13 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2483354122"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2483354122\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2483354122?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-15 07:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483354122","market":"fut","top_or_hot":-1,"title":"Exicure Signs Equity-Financing Deals With HiTron Systems","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n</p>\n<p>\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n</p>\n<p>\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n</p>\n<p>\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n</p>\n<p>\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 18:13 ET (23:13 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones & Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Exicure Signs Equity-Financing Deals With HiTron Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExicure Signs Equity-Financing Deals With HiTron Systems\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-11-15 07:13</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Connor Hart \n</p>\n<pre>\n \n</pre>\n<p>\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n</p>\n<p>\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n</p>\n<p>\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n</p>\n<p>\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n</p>\n<p>\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 14, 2024 18:13 ET (23:13 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones & Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4215","symbol_name":"住宅房地產投資信託","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2483354122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483354122","pubTimestamp":1731625980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company.The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday.Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest.Shares edged 1.3% lower, to $3.14, in after-hours trading.The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4215":"住宅房地产投资信托","XCUR":"Exicure, Inc.","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股","EQR":"资产住宅公司"},"translate_title":"Exicure与HiTron Systems签署股权融资协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EQR":1,"XCUR":0.9},"content_text":"By Connor Hart \n\n\n \n\n\n  Exicure has inked two equity-financing deals, receiving $10 million in exchange for a controlling interest in the company. \n\n\n  The Chicago biotechnology company will receive $1.3 million from HiTron Systems, a South Korean security-systems provider, for 433,333 shares of its common stock. Upon the deal's closing, HiTron will have the right to appoint two nominees to the Exicure's board, subject to certain conditions, it said Thursday. \n\n\n  Separately, Exicure will sell an additional 2.9 million shares of its common stock to HiTron, also for $3 apiece, or $8.7 million. Upon closing of this subsequent investment, HiTron will have the right to appoint additional nominees in proportion to its equity interest. \n\n\n  Shares edged 1.3% lower, to $3.14, in after-hours trading. \n\n\n  The company, which previously received an extension to show compliance with all applicable listing criteria by Nov. 14, believes it will meet these requirements following its equity-financing deals. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 18:13 ET (23:13 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1}}}